The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
Preformed Line Products Company
PLPC · Nasdaq · USD · Market cap $1.8B · 3,734 employees
Preformed Line Products Company designs and manufactures products and systems employed in the construction and maintenance of overhead, ground-mounted, and underground networks in the United States, the Americas, Europe,…
PASS · Titan Ethical · score 70.0Price as of 27 Oct 2026Daily close, not a live quote
Screened 2026-10-27 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price349.42 USD at the 27 Oct 2026 close
- Ethical screenPasses, score 70.0 out of 100
- Last reviewed27 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 349.42 against the desk's fair-value range, base estimate 480.00, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Preformed Line Products Company holds its Distribution at $349.42. The statistical read favours the sellers, held for 23 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 23 days |
| Price at the screen | $349.42 |
| Valuation | 40.75 trailing · N/A forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.90 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 7.21% | Below 33% | Interest-bearing debt is just 7.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 30.07% | Below 49% | Money owed to the company is 30.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.35% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Preformed Line Products clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 7%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PLPC's ethical verdict changes
Today PLPC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 32.8% margin of safety to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGrid hardware firm shows growth but slim profits
Every time a storm hits or a new solar array goes live, crews need tough clamps and connectors to keep the wires up. Preformed Line Products makes those essential bits for power networks from the Americas to Asia Pacific. Demand looks solid right now.
Revenue is rising 19 percent, the shares sit 14 percent below our fair value mark and the ethical screen is clear. Yet profit margins of 5 percent and an 8 percent return on equity do not build much excitement, and the lack of a known moat explains why we pass.
Utility budgets can swing hard with interest rates and raw material costs, while overseas sales add currency noise. Thin returns on capital could stay that way if bigger rivals crowd in. Analysis, not advice.
| Trailing P/E | 40.8xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 8.87 |
| Revenue growth | +25.4%strong top-line growth |
| Profit margin | 5.8%thin but positive margins |
| Return on equity | 9.0%a modest return on shareholder capital |
| FCF yield | 1.10% |
| Dividend yield | 22.00% |
| Debt to equity | 0.11minimal debt: a conservative balance sheet |
| Current ratio | 2.99comfortably covers its short-term bills |
| Beta | 0.90steadier than the market |
| Short interest, float | 0.07% |
| 52-week range | 184.02 - 504.69 |
| Market cap | $1.8B |
| Employees | 3,734 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePLPC trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Preformed Line Products (PLPC) Stock May Look Rich On Its Earnings Story Yahoo Finance · 9d ago
- PLPC Stock Surges 105% in a Year: What's Driving the Rally? Zacks · 18 Sep 2026
- PLPC Stock Surges 105% in a Year: What's Driving the Rally? Yahoo Finance · 18 Sep 2026
- PREFORMED LINE PRODUCTS ANNOUNCES QUARTERLY DIVIDEND Yahoo Finance · 17 Sep 2026
- The Zacks Analyst Blog Highlights Amazon, Marvell, Starbucks, Preformed Line Products and Crown Crafts Zacks · 4 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $356.98 | -1.1% | · | $989 | -1.1% |
| 2 months | $311.97 | +13.2% | · | $1,132 | +13.2% |
| 3 months | $260.64 | +35.5% | $0.21 | $1,356 | +35.6% |
| 6 months | $231.09 | +52.8% | $0.42 | $1,530 | +53.0% |
| 1 year | $152.36 | +131.8% | $0.82 | $2,323 | +132.3% |
| 2 years | $126.92 | +178.2% | $1.62 | $2,795 | +179.5% |
| 3 years | $162.16 | +117.8% | $2.42 | $2,192 | +119.2% |
| 5 years | $76.43 | +362.0% | $4.02 | $4,672 | +367.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PLPC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.